Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Thanks, Steady. That is the way I would explain it. If there were value @ $32/share, then the true value must be much higher as these drugs of Anavex are not bolt-on additions, but the real deal directly producing positive results, and possible improvement in the afflicted, in a safe manner.
tschussmann, rate similar to Fidelity. Someone posted awhile back that his/her was in the 12% range.
Thanks for your replies. I don't read all the posts like I did as I'm doing more useful things these days.
Thanks, tschussmann ... we are with Fidelity and it is offering less than 3% last time I looked about 2 weeks ago.
Ziggy, just to keep you current of what some of us know ... other than some option exercising, Anavex did not sell any shares from 9/30/2023 to 2/7/2024 when its Q1 numbers were released. Even after the ped Rett data was released on 1/2/2024, there were no sales thru that February date.
tschussmann, which brokerage firm and what rate are you receiving?
Just for the record on stock sales: Between September 30th (FYE) and February 7 (December 10-Q filed), there were only 54,000 shares issued, which were probably a result of Fadiran's departure. So, for 4+ months, Anavex did not issue any other shares for stock sales.
It will be interesting to see the numbers when March 10-Q is filed in early May.
What signal?
If you read this board often, you know that when Talon and John K emerge from long silences, the "quiet period" issue is raised as to why no PR's ... and still no news. This isn't about SEC-type "QP" rules, it is about a MB posters making claims with no basis.
nidan and Talon, there is no quiet period. If there were, then TGD would not have been present at Cowan on Tuesday ... and one did not start after that meeting. Just normal silence.
There is a lot going on behind the scenes, but nothing that would be called a "quiet period."
plex, how was Dr. Grimmer's presentation?
Peace
mrp, I thought he was very pleased with 2-73. It was one of the reasons he was invited to the SAB … and hasn’t left.
It is Grimmer, not Sabbagh, tomorrow in Europe, mrp.
mrp, do you mean this?
Biogen Surges On A Setback For Eli Lilly's Rival Alzheimer's Treatment
https://finance.yahoo.com/m/c59df32f-a373-340b-a4b8-563f1e5e8f48/biogen-surges-on-a-setback.html
Thanks, for answering the question, which you didn't ... only throwing out more 💩!
Has the fda made a decision? I thought it was the arbiter ... here is the States.
mrp, did those other companies cite a few days ago that received fda approval, did they claim "We failed" when issuing their PR's? Of course NOT! They made similar statements that the steps were to visit with the fda and discuss next course of action. Precisely, what Anavex is doing. However, I still claim:
WE GOT THIS and management should start acting like it.
ANAVEX NOW ... RIGHT NOW ... MONO-STYLE ... for LIFE ... and for ALL AGES!!!
mrp, I'm disappointed that more hasn't been made known to us, but I know it has to do with the strategy of having a transformational drug that will cause many changes in the medical field with a pipeline of other such drugs. I stand by my statement of earlier today:
WE GOT THIS and management should start acting like it.
ANAVEX NOW ... RIGHT NOW ... MONO-STYLE ... for LIFE ... and for ALL AGES!!!
Why, nidan, are you disappointed?
I make sure no one gets in my way as I swim to save from drowning a "Don't Got This" weighed down by FUD. Once s/he loses that weight, s/he will be able to swim effortlessly to the River of Tranquility.
Once again, the fda, mrp, will decide if Rett Peds' trial failed ... not you, Doc, Investor, froll et al.
WE GOT THIS and management should start acting like it.
ANAVEX NOW ... RIGHT NOW ... MONO-STYLE ... for LIFE ... and for ALL AGES!!!
It's a 'mab like Biosh**t's are ... dona*mab, I think is its name.
bas, you have #42!!
Need to add as manufacturing appears set:
Pantheon is part of Thermo Fisher Scientific, a very good group to be a part. The USA and Americas is covered.
Syntegon's headquarters are in Waiblingen (Germany). The largest location of the Syntegon Group is Crailsheim (Germany). Europe is covered.
JJ, the NYC comment was made 7-8 years ago as answer to the question if Anavex had enough product for the P2a trial in Australia.
It also, given the financial statement released at that time, implied the cost of production of one pill was less than a buck, and possibly as low as sixty cents … back then.
finch, I obviously disagree. Science will transformation; TGD will eventually get complete credit for the blarcamesine management, though the feathers ruffled by his silence will take awhile to be back in place.
P.S. I hope you visit your friends in Carmel often!😉
mrp, this might be what you are looking for as it indicates phone numbers and email addresses are available.
FYI - Per this site, it states that Anavex has 56 employees as of 2/23/24, but it includes Fadiran, so use 55. The graph shown stating locations where employees are needs updating as it adds up to 39. The listing does not show any off-site employees, so if the graph still holds, there are 55 in USA and 2 overseas for a total of 57.
https://www.zoominfo.com/pic/anavex-life-sciences/348122639?pageNum=3
george, your posts really brings up a good point which I'm sure mrp would agree.
Anavex has data on Australians in the two Alzheimer's trials, Rett ped trial (in Australia, the p might have been <.05), PDD trial (for which, Spain was the main focus); I am unsure of Rett adults, given the small number of participants.
So, Anavex could/should cobble together all the Down Under data for all the trials there and present a case for approval for all of them. If it has not done this by now, then the Aussie, Hammonds (?), should be flying over to NYC and make the case to do so.
WE GOT THIS and management should start acting like it.
ANAVEX NOW ... RIGHT NOW ... MONO-STYLE ... for LIFE ... and for ALL AGES!!!
finch, has there been any other director(s) leaving than Fadiran, who was replaced by a very skilled person, per his resumé?
As an aside, finch, we think this spring like weather might be real here in NW Indiana as some of the finches on our feeders are starting to show a little color ... yellow, that is, not blue!
P.P.S. That s/b "day" not say. Fat fingers!
BIO*4, you are correct that Anavex rarely gives more than a say or two warning on presentation at these type conferences. This one is a week ...sweet!
P.S. Sorry that your factual comment gets shi**ed upon by the "pro-bot-like" analysts(?).
Thank you for your service, Jesse, to one of our allies. Also, sorry for transposing your moniker.
William and plex, is this a conference that MobileMayo might attend? If he is able and does, it might mean he thinks he might get new insight, especially if he is able to speak with Dr. Grimmer afterwards.
So, mrp, if that were true, one of two things would need to happen:
1) AD trial failed and if so, the company would have to release a PR stating such. So far, it hasn't which probably means the trial was successful.
and,
2) If no one were willing to do the peer review, then Anavex would need to release a PR, stating such, as it has become a material statement by TGD that would need to be publicly withdrawn if it were not happening. That again hasn't happened, so, IMO, the peer review is forthcoming.
Thanks, Xena, for posting for everyone.
The Future of Medicine Is Unfolding Before Us. Are We Nurturing It?
Article emphasis on Sarepta from one effected doctor's personal perspective.
https://www.nytimes.com/2024/02/19/opinion/gene-therapy-dmd-elevidys.html?smid=nytcore-ios-share&referringSource=articleShare
Thanks, plex. So, do you think that the peer review paper will be released before this presentation?
If not, wouldn't Dr. M and Anavex be concerned too much might be disclosed?
TIA
george, do you have a link?
TIA
There is one mention of NYC ... in the address of the company. So, that proves what?
Also, our financial sources run through Chicago where Lincoln Capital is located. So, why no Chicago?
P.S. george, it is "capital", with an "a", not with an "o".
But, george, the fda is in Washington, D.C. Almost all defense contractors have moved their HQ's there to be closer to the decision makers. Anavex's decisions makers in the fda are in D.C. Moving there is not a ridiculous proposal!
https://finance.yahoo.com/news/biogen-plunges-alzheimer-drug-slow-175332780.html?.tsrc=fin-notif
P.S. Sorry, if previously posted.
Actually, both the dosed and placebo groups changed by roughly same amounts: dosed, -2.61 for dosed, and -2.65. I would not state that the dosed was "steady" and "reaches its full efficacy" while the placebo increased ... not true.
Maybe, it is your goggles that are too thick ... like your head!
I guess Investor's view about you might be correct ... and I hate to state that.